阿昔替尼诱导的肠壁积气症和急性非结石性胆囊炎一例:肾细胞癌患者
一例71岁转移性肾细胞癌男性患者在阿昔替尼治疗期间出现腹痛,诊断为阿昔替尼诱导的肠壁积气症(PI)和急性非结石性胆囊炎(AC)。经抗生素、肠道休息和停用阿昔替尼后病情改善。这是文献首例报告。
要点
- 阿昔替尼治疗期间出现腹痛需警惕肠壁积气症和急性非结石性胆囊炎。
- 停用阿昔替尼、抗生素和肠道休息后病情改善。
- 其他血管内皮生长因子受体酪氨酸激酶抑制剂诱发的PI和AC停药后通常自限,但部分可危及生命。
核心结论
- 阿昔替尼可诱导肠壁积气症和急性非结石性胆囊炎,这是文献首例报告。
研究设计与样本
- 病例报告:一例71岁转移性肾细胞癌男性患者。
主要发现
- 患者在阿昔替尼治疗期间出现腹痛,诊断为阿昔替尼诱导的肠壁积气症和急性非结石性胆囊炎。
- 经抗生素、肠道休息和停用阿昔替尼后病情改善。
临床怎么用
- 作者认为需认识阿昔替尼诱导的肠壁积气症和急性非结石性胆囊炎,以避免延迟或不恰当的治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 71-year-old man with metastatic renal cell carcinoma presented with abdominal pain during treatment with axitinib. The diagnoses were axitinib-induced pneumatosis intestinalis (PI) and acute acalculous cholecystitis (AC). The patient's condition improved with antibiotics, bowel rest, and discontinuation of the axitinib therapy. This is the first case report in the literature. PI and AC induced by other vascular endothelial growth factor receptor tyrosine kinase inhibitors are usually self-limiting upon discontinuation of those uses, but can be life-threatening in some cases. We need to be aware of axitinib-induced PI and AC to avoid delayed or inappropriate treatments for them.
引用
- Kameda T, Nakano K, Yamazaki M, et al. Axitinib-induced Pneumatosis Intestinalis and Acute Acalculous Cholecystitis in a Patient With Renal Cell Carcinoma. Urology. 2016. PMID: 28039049. doi:10.1016/j.urology.2016.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。